CLINICAL_TRIALS
trial_result
· 2013-12-02
Clinical Trial Update: CLARITY Extension Study [Phase 3]
Summary
Phase 3 extension study update for relapsing-remitting multiple sclerosis; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2013-12-02